Kuwait Prediabetes Market Size & Outlook, 2025-2030
Related Markets
Kuwait prediabetes market highlights
- The Kuwait prediabetes market generated a revenue of USD 0.8 million in 2024 and is expected to reach USD 1.3 million by 2030.
- The Kuwait market is expected to grow at a CAGR of 7.7% from 2025 to 2030.
- In terms of segment, diguanide was the largest revenue generating drug class in 2024.
- Glucagon-like peptide-1 agonists (GLP-1) is the most lucrative drug class segment registering the fastest growth during the forecast period.
Prediabetes market data book summary
| Market revenue in 2024 | USD 0.8 million |
| Market revenue in 2030 | USD 1.3 million |
| Growth rate | 7.7% (CAGR from 2025 to 2030) |
| Largest segment | Diguanide |
| Fastest growing segment | Glucagon-like peptide-1 agonists (GLP-1) |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diguanide, Thiazolidinediones, Glucagon-like peptide-1 agonists (GLP-1), SGLT2 inhibitors, DPP-4 inhibitors |
| Key market players worldwide | Novo Nordisk A/S ADR, Resverlogix Corp, AstraZeneca PLC, Bristol-Myers Squibb Co, Valbiotis, Caelus Health, SciMar, Boston Therapeutics, Aphaia |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.3% of the global prediabetes market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia prediabetes market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 1.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Prediabetes Market Scope
Prediabetes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Aphaia | View profile | 1-10 | London, England, United Kingdom, Europe | http://www.aphaia.co.uk |
| Boston Therapeutics | View profile | 11-50 | Lawrence, Massachusetts, United States, North America | http://www.bostonti.com |
| SciMar | View profile | 1-10 | Dauphin, Manitoba, Canada, North America | https://scimar.ca |
| Caelus Health | View profile | 1-10 | Amsterdam, Noord-Holland, The Netherlands, Europe | http://caelushealth.com/ |
| Valbiotis | View profile | 11-50 | La Rochelle, Poitou-Charentes, France, Europe | http://valbiotis.com/ |
| Resverlogix Corp | View profile | 18 | 4820 Richard Road South West, Suite 300, Calgary, AB, Canada, T3E 6L1 | https://www.resverlogix.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
Kuwait prediabetes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to prediabetes market will help companies and investors design strategic landscapes.
Diguanide was the largest segment with a revenue share of 87.5% in 2024. Horizon Databook has segmented the Kuwait prediabetes market based on diguanide, thiazolidinediones, glucagon-like peptide-1 agonists (glp-1), sglt2 inhibitors, dpp-4 inhibitors covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Kuwait prediabetes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Kuwait prediabetes market databook
-
Our clientele includes a mix of prediabetes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait prediabetes market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait prediabetes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Kuwait Age Group - Prediabetes Market size, 2024 - 2030 (US$M)
Kuwait Prediabetes Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
